130 related articles for article (PubMed ID: 11352902)
1. The YRD motif is a major determinant of substrate and inhibitor specificity in T-cell protein-tyrosine phosphatase.
Asante-Appiah E; Ball K; Bateman K; Skorey K; Friesen R; Desponts C; Payette P; Bayly C; Zamboni R; Scapin G; Ramachandran C; Kennedy BP
J Biol Chem; 2001 Jul; 276(28):26036-43. PubMed ID: 11352902
[TBL] [Abstract][Full Text] [Related]
2. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.
Simoncic PD; Lee-Loy A; Barber DL; Tremblay ML; McGlade CJ
Curr Biol; 2002 Mar; 12(6):446-53. PubMed ID: 11909529
[TBL] [Abstract][Full Text] [Related]
3. Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP.
Galic S; Hauser C; Kahn BB; Haj FG; Neel BG; Tonks NK; Tiganis T
Mol Cell Biol; 2005 Jan; 25(2):819-29. PubMed ID: 15632081
[TBL] [Abstract][Full Text] [Related]
4. The structure of PTP-1B in complex with a peptide inhibitor reveals an alternative binding mode for bisphosphonates.
Asante-Appiah E; Patel S; Dufresne C; Roy P; Wang Q; Patel V; Friesen RW; Ramachandran C; Becker JW; Leblanc Y; Kennedy BP; Scapin G
Biochemistry; 2002 Jul; 41(29):9043-51. PubMed ID: 12119018
[TBL] [Abstract][Full Text] [Related]
5. Parallel synthesis of a library of bidentate protein tyrosine phosphatase inhibitors based on the alpha-ketoacid motif.
Chen YT; Seto CT
Bioorg Med Chem; 2004 Jun; 12(12):3289-98. PubMed ID: 15158797
[TBL] [Abstract][Full Text] [Related]
6. Investigation of selective binding of inhibitors to PTP1B and TCPTP by accelerated molecular dynamics simulations.
Chen X; Gan Q; Feng C; Liu X; Zhang Q
J Biomol Struct Dyn; 2019 Sep; 37(14):3697-3706. PubMed ID: 30238851
[TBL] [Abstract][Full Text] [Related]
7. The noncatalytic C-terminal segment of the T cell protein tyrosine phosphatase regulates activity via an intramolecular mechanism.
Hao L; Tiganis T; Tonks NK; Charbonneau H
J Biol Chem; 1997 Nov; 272(46):29322-9. PubMed ID: 9361013
[TBL] [Abstract][Full Text] [Related]
8. Potent inhibition of protein tyrosine phosphatases by copper complexes with multi-benzimidazole derivatives.
Li Y; Lu L; Zhu M; Wang Q; Yuan C; Xing S; Fu X; Mei Y
Biometals; 2011 Dec; 24(6):993-1004. PubMed ID: 21618062
[TBL] [Abstract][Full Text] [Related]
9. Thermodynamic study of ligand binding to protein-tyrosine phosphatase 1B and its substrate-trapping mutants.
Zhang YL; Yao ZJ; Sarmiento M; Wu L; Burke TR; Zhang ZY
J Biol Chem; 2000 Nov; 275(44):34205-12. PubMed ID: 10952978
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Simulations of A27S and K120A Mutated PTP1B Reveals Selective Binding of the Bidentate Inhibitor.
Chen X; Liu X; Gan Q; Feng C; Zhang Q
Biomed Res Int; 2019; 2019():9852897. PubMed ID: 30729132
[TBL] [Abstract][Full Text] [Related]
11. Association of the T-cell protein tyrosine phosphatase with nuclear import factor p97.
Tiganis T; Flint AJ; Adam SA; Tonks NK
J Biol Chem; 1997 Aug; 272(34):21548-57. PubMed ID: 9261175
[TBL] [Abstract][Full Text] [Related]
12. Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.
Jia Z; Ye Q; Dinaut AN; Wang Q; Waddleton D; Payette P; Ramachandran C; Kennedy B; Hum G; Taylor SD
J Med Chem; 2001 Dec; 44(26):4584-94. PubMed ID: 11741477
[TBL] [Abstract][Full Text] [Related]
13. Potent, selective inhibitors of protein tyrosine phosphatase 1B.
Xin Z; Oost TK; Abad-Zapatero C; Hajduk PJ; Pei Z; Szczepankiewicz BG; Hutchins CW; Ballaron SJ; Stashko MA; Lubben T; Trevillyan JM; Jirousek MR; Liu G
Bioorg Med Chem Lett; 2003 Jun; 13(11):1887-90. PubMed ID: 12749891
[TBL] [Abstract][Full Text] [Related]
14. VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates.
Chen L; Montserat J; Lawrence DS; Zhang ZY
Biochemistry; 1996 Jul; 35(29):9349-54. PubMed ID: 8755712
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.
Sangwan V; Paliouras GN; Abella JV; Dubé N; Monast A; Tremblay ML; Park M
J Biol Chem; 2008 Dec; 283(49):34374-83. PubMed ID: 18819921
[TBL] [Abstract][Full Text] [Related]
16. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
17. Transition state analysis and requirement of Asp-262 general acid/base catalyst for full activation of dual-specificity phosphatase MKP3 by extracellular regulated kinase.
Rigas JD; Hoff RH; Rice AE; Hengge AC; Denu JM
Biochemistry; 2001 Apr; 40(14):4398-406. PubMed ID: 11284696
[TBL] [Abstract][Full Text] [Related]
18. The T-cell protein tyrosine phosphatase is phosphorylated on Ser-304 by cyclin-dependent protein kinases in mitosis.
Bukczynska P; Klingler-Hoffmann M; Mitchelhill KI; Lam MH; Ciccomancini M; Tonks NK; Sarcevic B; Kemp BE; Tiganis T
Biochem J; 2004 Jun; 380(Pt 3):939-49. PubMed ID: 15030318
[TBL] [Abstract][Full Text] [Related]
19. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
20. Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors.
Pei Z; Li X; Liu G; Abad-Zapatero C; Lubben T; Zhang T; Ballaron SJ; Hutchins CW; Trevillyan JM; Jirousek MR
Bioorg Med Chem Lett; 2003 Oct; 13(19):3129-32. PubMed ID: 12951078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
